Royal Bank of Canada
IRON icon

Royal Bank of Canada’s Disc Medicine IRON Stock Holding History

Royal Bank of Canada’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73K Buy
989
+965
+4,021% +$66.3K ﹤0.01% 5583
2026
Q1 		$2K Sell
24
-778
-97% -$54K ﹤0.01% 6707
2025
Q4 		$64K Sell
802
-15,894
-95% -$1.34M ﹤0.01% 5421
2025
Q3 		$1.1M Sell
16,696
-5,903
-26% -$351K ﹤0.01% 3914
2025
Q2 		$1.2M Buy
22,599
+21,401
+1,786% +$1.01M ﹤0.01% 3739
2025
Q1 		$59K Sell
1,198
-1,248
-51% -$69.4K ﹤0.01% 5506
2024
Q4 		$155K Buy
2,446
+283
+13% +$16.4K ﹤0.01% 5025
2024
Q3 		$107K Buy
2,163
+339
+19% +$15.9K ﹤0.01% 5298
2024
Q2 		$83K Buy
1,824
+1,481
+432% +$50.3K ﹤0.01% 5376
2024
Q1 		$21K Sell
343
-2,308
-87% -$150K ﹤0.01% 5899
2023
Q4 		$153K Buy
2,651
+1,522
+135% +$77.9K ﹤0.01% 5314
2023
Q3 		$53K Buy
1,129
+627
+125% +$31.4K ﹤0.01% 5750
2023
Q2 		$22K Buy
502
+402
+402% +$14.3K ﹤0.01% 6167
2023
Q1 		$2K Buy
+100
New +$2.23K ﹤0.01% 6774
2022
Q4 		– Sell
-4
Closed – – 7460
2022
Q3 		$0 Buy
+4
New +$189 ﹤0.01% 7632
2022
Q2 		– Sell
-52
Closed -$2K – 7534
2022
Q1 		$2K Sell
52
-110
-68% -$5.77K ﹤0.01% 7482
2021
Q4 		$14K Buy
162
+99
+157% +$9.7K ﹤0.01% 6944
2021
Q3 		$7K Buy
63
+13
+26% +$1.78K ﹤0.01% 7059
2021
Q2 		$10K Buy
+50
New +$16.4K ﹤0.01% 6871

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Royal Bank of Canada's IRON Position: Q2 2026 in Review

Royal Bank of Canada increased its Disc Medicine (IRON) stake by 4,021% in Q2 2026, buying an estimated $66.3K and bringing the position to 989 shares worth $73K. The position accounts for ﹤0.01% of the portfolio, ranked #5583.

Royal Bank of Canada first reported a position in IRON in Q2 2021 and has held it in 19 quarters since. The position peaked at $1.2M in Q2 2025. 215 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Royal Bank of Canada held 989 shares of Disc Medicine worth $73K as of Q2 2026.
  • Royal Bank of Canada bought 965 Disc Medicine shares in Q2 2026, an estimated $66.3K.
  • Disc Medicine made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #5583 holding.
  • Royal Bank of Canada first reported a position in Disc Medicine in Q2 2021 and has held it in 19 quarters since.
  • Royal Bank of Canada's Disc Medicine position peaked at $1.2M in Q2 2025.
  • 215 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.